ARRKX
Price
$14.57
Change
+$0.14 (+0.97%)
Updated
Apr 24 closing price
Net Assets
30.96M
MGLIX
Price
$15.77
Change
+$0.13 (+0.83%)
Updated
Apr 24 closing price
Net Assets
2.19B
Ad is loading...

ARRKX vs MGLIX

Header iconARRKX vs MGLIX Comparison
Open Charts ARRKX vs MGLIXBanner chart's image
AB Global Real Estate Investment K
Price$14.57
Change+$0.14 (+0.97%)
VolumeN/A
Net Assets30.96M
MFS Global Real Estate I
Price$15.77
Change+$0.13 (+0.83%)
VolumeN/A
Net Assets2.19B
ARRKX vs MGLIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARRKX vs. MGLIX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRKX is a Buy and MGLIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.19B vs. ARRKX (31M). MGLIX pays higher dividends than ARRKX: MGLIX (2.61) vs ARRKX (1.79). ARRKX was incepted earlier than MGLIX: ARRKX (20 years) vs MGLIX (16 years). ARRKX (2.01) is less costly to investors than MGLIX (0.95). ARRKX is a more actively managed with annual turnover of: 56.00 vs. MGLIX (48.00). ARRKX (0) and MGLIX (0) have matching initial minimum investment requirements. ARRKX annual gain was more profitable for investors over the last year : 10.46 vs. MGLIX (2.35). ARRKX return over 5 years is better than : 37.44 vs. MGLIX (21.58).
ARRKXMGLIXARRKX / MGLIX
Total Expense Ratio2.010.94214%
Annual Report Gross Expense Ratio2.010.95212%
Fund Existence20 years16 years-
Gain YTD1.477-2.494-59%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets31M2.19B1%
Annual Yield % from dividends1.792.6169%
Returns for 1 year10.462.35446%
Returns for 3 years-9.00-21.1643%
Returns for 5 years37.4421.58174%
Returns for 10 years23.9519.21125%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOCQX43.02N/A
N/A
Tocqueville
JFNAX63.90N/A
N/A
Janus Henderson Global Life Sciences A
GMVRX14.37N/A
N/A
Goldman Sachs Small/Mid Cap Value R
NSFOX10.22N/A
N/A
Natixis Target Retirement 2065 N
GTDIX33.14N/A
N/A
Invesco EQV Emerging Markets All Cap R5